Ironwood Investment Counsel’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-6,500
Closed -$233K 202
2020
Q4
$233K Hold
6,500
0.05% 190
2020
Q3
$248K Sell
6,500
-500
-7% -$19.3K 0.07% 171
2020
Q2
$245K Hold
7,000
0.07% 163
2020
Q1
$228K Sell
7,000
-16
-0.2% -$625 0.09% 149
2019
Q4
$317K Buy
7,016
+16
+0.2% +$669 0.11% 131
2019
Q3
$284K Hold
7,000
0.1% 130
2019
Q2
$300K Hold
7,000
0.11% 125
2019
Q1
$268K Hold
7,000
0.11% 130
2018
Q4
$247K Hold
7,000
0.11% 126
2018
Q3
$269K Buy
+7,000
New +$244K 0.1% 131
2017
Q4
Sell
-7,000
Closed -$204K 147
2017
Q3
$204K Buy
+7,000
New +$193K 0.08% 140
2015
Q1
Sell
-10,510
Closed -$139K 142
2014
Q4
$139K Hold
10,510
0.07% 138
2014
Q3
$124K Sell
10,510
-500
-5% -$6.3K 0.07% 132
2014
Q2
$141K Buy
+11,010
New +$143K 0.07% 134

Other funds holding BSX

Ironwood Investment Counsel's BSX Position: Q1 2021 in Review

Ironwood Investment Counsel sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 6,500 shares — an estimated $233K sold.

Ironwood Investment Counsel first reported a position in BSX in Q2 2014 and held it in 14 quarters. The position peaked at $317K in Q4 2019. 831 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Ironwood Investment Counsel reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Ironwood Investment Counsel sold 6,500 Boston Scientific shares in Q1 2021, an estimated $233K.
  • Ironwood Investment Counsel first reported a position in Boston Scientific in Q2 2014 and held it in 14 quarters.
  • Ironwood Investment Counsel's Boston Scientific position peaked at $317K in Q4 2019.
  • 831 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Ironwood Investment Counsel's 13F filing for Q1 2021, filed 3 May 2021.